Table 2.
Summary of GUPI and SF-12 total and sub-scores at enrollment and at one-year follow-up.
| IC/BPS | OPPC | p-value from t-test to compare IC/BPS and OPPC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Change from baseline | p-value1 | Baseline | Follow-up | Change from baseline | p-value1 | Baseline | Follow-up | Change | |
| GUPI, N | 308 | 183 | 183 | 85 | 65 | 65 | |||||
| Mean (SD)2 | Mean (SD)2 | Mean (SD)3 | Mean (SD)2 | Mean (SD)2 | Mean (SD)3 | ||||||
| Pain Symptom | 12.5 (6.1) | 14.0 (5.9) | 1.1 (4.5) | 0.002 | 16.6 (6.1) | 18.1 (5.4) | 1.2 (3.9) | 0.022 | <.001 | <.001 | 0.806 |
| Urinary Symptom | 4.1 (2.9) | 4.8 (2.9) | 0.5 (2.4) | 0.009 | 6.1 (2.9) | 6.5 (2.5) | 0.3 (2.3) | 0.303 | <.001 | <.001 | 0.624 |
| QoL sub-score | 4.8 (3.3) | 5.4 (3.2) | 0.6 (2.4) | <.001 | 7.0 (3.5) | 7.7 (3.2) | 0.6 (2.4) | 0.039 | <.001 | <.001 | 0.952 |
| Total | 21.4 (10.9) | 24.3 (10.5) | 2.1 (7.5) | <.001 | 29.8 (11.2) | 32.4 (9.9) | 2.1 (7.1) | 0.018 | <.001 | <.001 | 0.993 |
| SF-12, N | 308 | 196 | 196 | 85 | 62 | 62 | |||||
| Mean (SD)2 | Mean (SD)2 | Mean (SD)3 | Mean (SD)2 | Mean (SD)2 | Mean (SD)3 | ||||||
| Physical Health | 38.7 (11.0) | 38.2 (9.5) | −0.3 (8.8) | 0.722 | 41.6 (12.0) | 40.8 (11.4) | −1.3 (7.3) | 0.238 | 0.039 | 0.072 | 0.422 |
| Mental Health | 42.6 (12.8) | 44.1 (11.9) | 0.7 (10.5) | 0.612 | 46.3 (11.4) | 43.9 (12.2) | −2.2 (8.3) | 0.043 | 0.015 | 0.902 | 0.046 |
| Total | 81.3 (16.6) | 82.3 (14.9) | 0.4 (11.0) | 0.413 | 87.9 (16.8) | 84.7 (17.9) | −3.5 (10.8) | 0.027 | 0.001 | 0.294 | 0.015 |
Bolded items are statistically significant (p < 0.05).
BPS, Bladder pain syndrome; IC, Interstitial cystitis; GUPI, Genitourinary Pain Index; OPPC, Other pelvic pain conditions; SF-12, 12-item Short Form Health Survey.
1
Wilcoxon Signed-rank test to test the score change at one-year follow-up from baseline within each cohort.
2
A higher number means better health condition.
3
A positive number indicates health condition improved from baseline.